Avanos Medical (AVNS) PT Lowered to $47 at KeyBanc

August 4, 2021 4:16 AM

KeyBanc analyst Matthew Mishan lowered the price target on Avanos Medical (NYSE: AVNS) to $47.00 (from $55.00) while maintaining a Overweight rating.

No results found